Autoimmune thyroiditis in manic-depressive patients treated with lithium.

Area of Science:

• Endocrinology
• Immunology
• Psychiatry

Background:

• Lithium is a common treatment for bipolar disorder.
• Thyroid dysfunction, including hypothyroidism, is a known side effect of lithium therapy.
• The mechanisms underlying lithium-induced thyroid dysfunction are not fully understood.

Purpose of the Study:

• To investigate if lithium treatment exacerbates underlying autoimmune thyroiditis.
• To assess the relationship between lithium therapy and thyroid antibody titers.

Main Methods:

• Comprehensive assessment of thyroid function in 16 patients with bipolar disorder undergoing lithium treatment.
• Monitoring of thyroid antibody titers (thyroid microsomal antibodies) before and during lithium therapy (4-12 months).

Main Results:

• Three patients with detectable thyroid antibodies pretreatment showed a marked increase in titer after 4-12 months of lithium treatment.
• Lithium-induced thyroid dysfunction may involve exacerbation of pre-existing autoimmune thyroiditis.

Conclusions:

• Lithium's effect on thyroid function may extend beyond direct thyroid impact.
• Lithium may exacerbate latent autoimmune thyroiditis, potentially through alterations in T lymphocyte subpopulations.